SL
TMDX icon

Salomon & Ludwin’s Transmedics TMDX Stock Holding History

Salomon & Ludwin’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.3K Hold
241
– – ﹤0.01% 949
2025
Q4 		$30.4K Sell
241
-4
-2% -$502 ﹤0.01% 603
2025
Q3 		$28.3K Buy
+245
New +$28.7K ﹤0.01% 615

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Salomon & Ludwin's TMDX Position: Q1 2026 in Review

Salomon & Ludwin held its Transmedics (TMDX) position steady in Q1 2026 at 241 shares worth $24.3K. The position accounts for ﹤0.01% of the portfolio, ranked #949.

Salomon & Ludwin first reported a position in TMDX in Q3 2025 and has held it in 3 quarters since. The position peaked at $30.4K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Salomon & Ludwin held 241 shares of Transmedics worth $24.3K as of Q1 2026.
  • Salomon & Ludwin left its Transmedics share count unchanged in Q1 2026.
  • Transmedics made up ﹤0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #949 holding.
  • Salomon & Ludwin first reported a position in Transmedics in Q3 2025 and has held it in 3 quarters since.
  • Salomon & Ludwin's Transmedics position peaked at $30.4K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.